Share
Share today's newsletter with a colleague
and get credit if they sign up for SmartBrief.
Referral Count:
0
Story being shared
Xarelto gains expanded indication from the FDA
The FDA approved expanded use of Johnson & Johnson's blood thinner Xarelto to treat and reduce patients' risk of deep vein thrombosis and pulmonary embolism recurrence.
Or we can send an email on your behalf